Company profile
McKesson Corporation
NYSE: MCK · Healthcare · Medical - Distribution
#2 of 1,417 Healthcare companies by revenue58th-percentile growth
EA Score
85AFH 84DQ 91GM 72SS 97
v0.1 · 65/100 weight · provisional
↑ market scale, disclosure history · ↓ revenue growth (YoY), 3-yr revenue growth
Methodology →Revenue TTM
$403.4B
Rev growth YoY (TTM)
+12.4%
Net income (FY)
$4.8B
Employees
43,000
as of 2026-08-04
Market cap
$96.6B
as of 2026-08-04
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$403.4B$403.4B2026
Net income$4.8B$4.8B2026
Operating income$6.2B$6.2B2026
Total assets$82.3B$82.3B2026
Equity-$2.2B-$2.2B2026
Revenue trend
FY2021 – FY2026 · USD
FY21
FY21
FY21
FY22
FY23
FY24
FY25
FY26
Revenue by segment
Filed disclosures · FY2026
By product
North American Pharmaceutical83%
Oncology And Multispecialty12%
Medical-Surgical Solutions3%
Prescription Technology Solutions1%
Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment0%
By geography
Not disclosed.
The read
What is McKesson Corporation’s revenue?
McKesson Corporation booked $403.4B in FY2026 revenue, growing 12% year over year — about the middle of the pack among Healthcare companies we track, at a 1.2% net margin.
Peers · Healthcare
UnitedHealth Group Incorporated80B+CVS Health Corp.83B+Cencora, Inc.84B+Cigna Corporation77B+Neighbors
Dallas →Key facts
CEOBrian S. Tyler
SectorHealthcare
IndustryMedical - Distribution
HeadquartersIrving, TX
ExchangeNYSE: MCK
Employees43,000
IPO date1994-11-10
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.